| Primary |
| Attention Deficit/hyperactivity Disorder |
52.2% |
| Drug Use For Unknown Indication |
20.4% |
| Product Used For Unknown Indication |
14.3% |
| Ill-defined Disorder |
1.9% |
| Depression |
1.6% |
| Asthma |
1.1% |
| Anxiety |
0.9% |
| Drug Exposure During Pregnancy |
0.8% |
| Epilepsy |
0.8% |
| Psychomotor Hyperactivity |
0.8% |
| Suicide Attempt |
0.7% |
| Disturbance In Attention |
0.7% |
| Narcolepsy |
0.6% |
| Multiple Allergies |
0.6% |
| Bipolar Disorder |
0.5% |
| Sleep Disorder |
0.5% |
| Aggression |
0.4% |
| Abnormal Behaviour |
0.4% |
| Autism |
0.4% |
| Foetal Exposure During Pregnancy |
0.4% |
|
| Suicidal Ideation |
11.3% |
| Suicide Attempt |
8.9% |
| Growth Retardation |
8.3% |
| Tachycardia |
7.6% |
| Weight Decreased |
7.2% |
| Psychotic Disorder |
6.9% |
| Vomiting |
6.4% |
| Tic |
5.5% |
| Weight Increased |
4.1% |
| Hypertension |
4.1% |
| Syncope |
3.6% |
| Hallucination |
3.5% |
| Overdose |
3.5% |
| Tremor |
3.2% |
| Insomnia |
3.2% |
| Depression |
2.8% |
| Convulsion |
2.7% |
| Haematuria |
2.5% |
| Headache |
2.3% |
| Weight Gain Poor |
2.3% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
54.6% |
| Product Used For Unknown Indication |
15.9% |
| Drug Use For Unknown Indication |
8.5% |
| Depression |
4.3% |
| Conduct Disorder |
2.0% |
| Ill-defined Disorder |
1.5% |
| Anxiety |
1.3% |
| Bipolar Disorder |
1.2% |
| Disturbance In Attention |
1.2% |
| Oppositional Defiant Disorder |
1.2% |
| Epilepsy |
1.1% |
| Aggression |
0.9% |
| Psychomotor Hyperactivity |
0.9% |
| Drug Exposure During Pregnancy |
0.8% |
| Dyspraxia |
0.8% |
| Sleep Disorder |
0.8% |
| Irritability |
0.7% |
| Multiple Allergies |
0.7% |
| Prophylaxis |
0.7% |
| Diabetes Mellitus |
0.7% |
|
| Tachycardia |
10.4% |
| Weight Decreased |
9.5% |
| Suicidal Ideation |
9.3% |
| Vomiting |
8.6% |
| Tic |
5.8% |
| Psychotic Disorder |
5.0% |
| Overdose |
4.8% |
| Tremor |
4.7% |
| Decreased Appetite |
4.4% |
| Headache |
4.0% |
| Growth Retardation |
3.9% |
| Weight Increased |
3.9% |
| Drug Ineffective |
3.6% |
| Suicide Attempt |
3.6% |
| Psychomotor Hyperactivity |
3.4% |
| Pyrexia |
3.1% |
| Syncope |
3.1% |
| Treatment Noncompliance |
3.1% |
| Depression |
3.0% |
| Vision Blurred |
2.8% |
|
| Concomitant |
| Attention Deficit/hyperactivity Disorder |
26.1% |
| Product Used For Unknown Indication |
14.1% |
| Depression |
9.2% |
| Drug Use For Unknown Indication |
8.1% |
| Bipolar Disorder |
7.3% |
| Pain |
4.8% |
| Anxiety |
3.9% |
| Acne |
3.1% |
| Asthma |
2.7% |
| Contraception |
2.6% |
| Crohn's Disease |
2.4% |
| Sleep Disorder |
2.2% |
| Multiple Sclerosis |
2.2% |
| Affective Disorder |
2.0% |
| Insomnia |
2.0% |
| Breast Cancer Metastatic |
1.8% |
| Migraine |
1.5% |
| Osteoporosis |
1.5% |
| Nausea |
1.3% |
| Hypersensitivity |
1.3% |
|
| Suicidal Ideation |
11.2% |
| Weight Increased |
10.9% |
| Vomiting |
10.3% |
| Weight Decreased |
7.6% |
| Tremor |
5.8% |
| Nausea |
5.4% |
| Rash |
4.8% |
| Type 2 Diabetes Mellitus |
4.8% |
| Drug Ineffective |
4.1% |
| Pulmonary Embolism |
4.1% |
| Suicide Attempt |
3.7% |
| White Blood Cell Count Decreased |
3.5% |
| Somnolence |
3.3% |
| Viral Pharyngitis |
3.3% |
| Electrocardiogram Qt Prolonged |
3.1% |
| Abdominal Pain |
2.9% |
| Pyrexia |
2.9% |
| Tic |
2.9% |
| Pain |
2.7% |
| Vision Blurred |
2.7% |
|
| Interacting |
| Attention Deficit/hyperactivity Disorder |
39.4% |
| Aggression |
12.1% |
| Smoking Cessation Therapy |
9.1% |
| Anxiety |
6.1% |
| Impulsive Behaviour |
6.1% |
| Personality Disorder |
6.1% |
| Conduct Disorder |
3.0% |
| Contraception |
3.0% |
| Emotional Disorder |
3.0% |
| Ex-tobacco User |
3.0% |
| Insomnia |
3.0% |
| Multiple Allergies |
3.0% |
| Sinusitis |
3.0% |
|
| Drug Interaction |
26.7% |
| Insomnia |
13.3% |
| Nausea |
13.3% |
| Balance Disorder |
6.7% |
| Change In Sustained Attention |
6.7% |
| Dyskinesia |
6.7% |
| Headache |
6.7% |
| Muscle Twitching |
6.7% |
| Swelling |
6.7% |
| Vomiting |
6.7% |
|
